BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9614567)

  • 1. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting.
    McKie EA; Graham DI; Brown SM
    Gene Ther; 1998 Apr; 5(4):440-50. PubMed ID: 9614567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter.
    Wang CY; Wang S
    Gene Ther; 2006 Oct; 13(20):1447-56. PubMed ID: 16724097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements.
    de Leeuw B; Su M; ter Horst M; Iwata S; Rodijk M; Hoeben RC; Messing A; Smitt PS; Brenner M
    J Neurosci Res; 2006 Apr; 83(5):744-53. PubMed ID: 16496373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: in vivo comparison of distinct GFAP-lacZ transgenes.
    Johnson WB; Ruppe MD; Rockenstein EM; Price J; Sarthy VP; Verderber LC; Mucke L
    Glia; 1995 Mar; 13(3):174-84. PubMed ID: 7782103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter.
    Vandier D; Rixe O; Besnard F; Kim M; Rikiyama T; Goldsmith M; Brenner M; Gouyette A; Cowan KH
    Cancer Gene Ther; 2000 Aug; 7(8):1120-6. PubMed ID: 10975672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A glial-specific, repressible, adenovirus vector for brain tumor gene therapy.
    Chen J; Bezdek T; Chang J; Kherzai AW; Willingham T; Azzara M; Nisen PD
    Cancer Res; 1998 Aug; 58(16):3504-7. PubMed ID: 9721849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor-beta 1 in astrocytes from distinct brain regions.
    Sousa Vde O; Romão L; Neto VM; Gomes FC
    Eur J Neurosci; 2004 Apr; 19(7):1721-30. PubMed ID: 15078546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GFAP promoter elements required for region-specific and astrocyte-specific expression.
    Lee Y; Messing A; Su M; Brenner M
    Glia; 2008 Apr; 56(5):481-93. PubMed ID: 18240313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression.
    Miyao Y; Shimizu K; Moriuchi S; Yamada M; Nakahira K; Nakajima K; Nakao J; Kuriyama S; Tsujii T; Mikoshiba K
    J Neurosci Res; 1993 Nov; 36(4):472-9. PubMed ID: 7505843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene.
    Lee Y; Su M; Messing A; Brenner M
    Glia; 2006 May; 53(7):677-87. PubMed ID: 16482522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression.
    Smith-Arica JR; Morelli AE; Larregina AT; Smith J; Lowenstein PR; Castro MG
    Mol Ther; 2000 Dec; 2(6):579-87. PubMed ID: 11124058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease.
    Do Thi NA; Saillour P; Ferrero L; Dedieu JF; Mallet J; Paunio T
    Gene Ther; 2004 May; 11(9):746-56. PubMed ID: 14724667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism.
    Segovia J; Vergara P; Brenner M
    Gene Ther; 1998 Dec; 5(12):1650-5. PubMed ID: 10023444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective killing of glioma cell lines using an astrocyte-specific expression of the herpes simplex virus-thymidine kinase gene.
    Vandier D; Rixe O; Brenner M; Gouyette A; Besnard F
    Cancer Res; 1998 Oct; 58(20):4577-80. PubMed ID: 9788604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal and pathological expression of GFAP promoter elements in transgenic mice.
    Galou M; Pournin S; Ensergueix D; Ridet JL; Tchélingérian JL; Lossouarn L; Privat A; Babinet C; Dupouey P
    Glia; 1994 Dec; 12(4):281-93. PubMed ID: 7890332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug inducible transgene expression in brain using a herpes simplex virus vector.
    Oligino T; Poliani PL; Wang Y; Tsai SY; O'Malley BW; Fink DJ; Glorioso JC
    Gene Ther; 1998 Apr; 5(4):491-6. PubMed ID: 9614573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of glial fibrillary acidic protein gene methylation in human malignant gliomas.
    Fukuyama K; Matsuzawa K; Hubbard SL; Dirks PB; Murakami M; Rutka JT
    Anticancer Res; 1996; 16(3A):1251-7. PubMed ID: 8702246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.
    Hede SM; Hansson I; Afink GB; Eriksson A; Nazarenko I; Andrae J; Genove G; Westermark B; Nistér M
    Glia; 2009 Aug; 57(11):1143-53. PubMed ID: 19115382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
    Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
    Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.